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Abstract
Introduction: We present a case of ciprofloxacin-associated pseudotumor cerebri in a 22-year-old African American
woman. Withdrawal of ciprofloxacin in our patient resulted in complete resolution of ciprofloxacin-associated
pseudotumor, as evidenced by a normal neuro-ophthalmic examination and a cerebrospinal fluid opening pressure
of 140 mmH20.
Case presentation: A 22-year-old African American woman presented with a headache of two weeks duration,
visual blurring and horizontal diplopia after starting ciprofloxacin for pyelonephritis. An ophthalmic examination
revealed that she had left eye esotropia, and a picture of the fundus demonstrated bilateral disc swelling without
spontaneous venous pulsations. Magnetic resonance imaging of the brain and a magnetic resonance venogram
were normal. A diagnostic lumbar puncture demonstrated an elevated opening pressure of 380mmH2O in a
supine position. Laboratory examinations, including a cerebrospinal fluid exam, were unremarkable.
Conclusion: ciprofloxacin-associated pseudotumor can cause chronic disabling headache and visual complications.
Therapy is sub-optimal, often symptomatic, insufficient and complicated by side effects. When ciprofloxacin-
associated pseudotumor presents in an atypical population, an inciting agent must be suspected because prompt
withdrawal of the agent may lead to complete resolution of symptoms and prevent recurrence of similar episodes.
Introduction
Pseudotumor cerebri (PTC) is a condition of increased
intracranial pressure (ICP) without clinical, laboratory
or radiological evidence of intracranial pathology. PTC
is traditionally a disease of middle-aged, obese women
and presents with symptoms of raised ICP, such as
headache, pulsatile tinnitus, transitory visual obscura-
tions and diplopia. PTC is a rare disease with increasing
prevalence due to a global increase in the prevalence of
obesity. The disease course is usually self-limiting, how-
ever some patients may experience chronic disabling
headache and visual disturbances. Early intervention is
necessary to prevent permanent visual defects from
ischemic optic neuropathy. The pathophysiology of PTC
is still not fully understood and so no real causal treat-
ment exists. The treatment of PTC instead focuses on
normalization of ICP, either medically or surgically.
Both types of treatment are often symptomatic, insuffi-
cient and are complicated by side effects. Identifying a
reversible cause may potentially reverse the disease and
prevent future episodes.
Case presentation
A 22-year-old African American woman presented with
a two-week history of generalized, continuous headache,
bilateral visual blurring and horizontal diplopia. With
the persistence of the symptoms, as well as development
of a left eye deviation, our patient was brought to our
hospital. She was admitted two weeks prior to an out-
side hospital and empirically treated for pyelonephritis
with 500 mg of ciprofloxacin twice daily for two weeks.
Symptoms began two days after starting ciprofloxacin
and worsened with continued treatment. She did not
have a history of recent ear infection, treatment for
acne, vitamin A supplementation, lead exposure, seizure
disorder, oral contraceptives, steroid intake or withdra-
wal. There was no history of tick bites, target rash or
joint pains. Her medical, surgical, travel and family his-
tory were all unremarkable.
On examination, our patient’sb o d ym a s si n d e xw a s
29.4. Her temperature was 37.2°C; heart rate 66/min,
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On ophthalmic examination, her corrected visual acuity
was 20/20 in her right eye and 20/40 in her left eye. She
had diplopia on her left lateral gaze with left eye esotro-
pia. The intra-ocular pressure, anterior segment and
papillary response were normal. The fundus picture
demonstrated bilateral disc swelling without sponta-
neous venous pulsations [Figure 1]. Both of her tympa-
nic membranes were intact, and there was no evidence
of bulging or discharge. She did not have neck rigidity
and Kernig and Brudzinski signs were negative. Cranial
nerves II to XII were intact. Manual muscle testing in
all extremities was 5/5, and deep-tendon reflexes were
all 2/4. Her cerebellar function was intact, as was gait,
and Babinski reflexes were downward bilaterally. Sensa-
tion was intact to pain and soft touch. Findings of an
examination of her lungs, heart, and abdomen were
benign. Magnetic resonance imaging of her brain with
and without contrast and a magnetic resonance veno-
gram were normal. A diagnostic lumbar puncture per-
formed in the recumbent position demonstrated an
opening pressure of 380 mmH2O. Her cerebrospinal
fluid (CSF) protein, glucose, cell count, veneral disease
research laboratory test (VDRL), herpes simplex virus 1
and 2, Toxoplasma, cryptococcal antigen, Gram stain,
acid fast bacilli stain, routine bacterial, viral, and fungal
cultures, and cytology were all normal. CSF protein elec-
trophoresis was normal without any oligoclonal bands.
Laboratory data, including a complete blood count,
chemistry panel (blood urea nitrogen of 16 mg/dL and
creatinine of 0.8 mg/dL), liver function tests, thyroid
function tests, sedimentation rate, anti-nuclear antibo-
dies, VDRL, rheumatoid factor, and angiotensin-convert-
ing enzyme, were all normal. A urine beta human
chorionic gonadotropin test was negative.
A diagnosis of PTC was made. Ciprofloxacin was dis-
continued and serial lumbar punctures returned the
opening pressure to 140 mmH2O. Our patient’ss y m p -
toms improved after each lumbar puncture. The
improvement of symptoms and subsequent reduction in
CSF opening pressure was consistent with the elimina-
tion half-life of the drug. She was discharged home with
close ophthalmology follow-up. Four weeks later, there
was complete resolution of papilledema [Figure 2].
Discussion
PTC has a rare, known association with members of the
fluoroquinolone family of drugs and no reported asso-
ciation with pyelonephritis. It was first reported with
nalidixic acid [1,2], the prototype drug of quinolone
antibiotics. In 1966, a nine-year-old girl, hospitalized
after an automobile injury resulting in multiple frac-
tures, developed minimal papilledema while receiving
nalidixic acid for a urinary tract infection; papilledema
disappeared when the drug was discontinued. In 1967,
the first reported case of nalidixic acid-associated pseu-
dotumor cerebri was reported [2]. Symptoms recurred
with rechallenge of nalidixic acid on two separate occa-
sions and subsided with discontinuation [2,3]. Plasma
nalidixic acid levels paralleled symptoms but were not
elevated [2]. Since then ofloxacin [4], pefloxacin [5] and
levofloxacin [6] have been associated with pseudotumor
cerebri as well as one prior case of ciprofloxacin-
induced disease [7]. Most cases have occurred in chil-
dren and young adults. Disease has also been associated
with non-fluoroquinilone antibiotics such as tetracycline
[8] minocycline [9], and doxycycline [10]. Ciprofloxacin
is a derivative of the drug nalidixic acid, with similar
structural properties. The close temporal relationship
between the use of ciprofloxacin and development of
Figure 1 Optic disc swelling after the initiation of ciprofloxacin.
Figure 2 Resolution of papilledema after the withdrawal of
ciprofloxacin.
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drawal, are only suggestive of a causal relationship. The
exact pathogenesis of PTC from fluoroquinolones
remains unclear.
Conclusion
Persistent headache and visual symptoms after treat-
ment with ciprofloxacin should prompt evaluation for
pseudotumor cerebri. Increased awareness of this
adverse effect is important, as ciprofloxacin is a widely
used antibiotic for many infections. This case illustrates
that despite the rarity of ciprofloxacin-induced PTC,
patients and physicians should be aware of this
possibility.
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